-------------------------------------------
OMB APPROVAL
-------------------------------------------
OMB Number:
Expires:
Estimated average burden
hours per form...................
-------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
AMERITRANS CAPITAL CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.0001 PAR VALUE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
03073H108
- --------------------------------------------------------------------------------
(CUSIP Number)
CRAIG H. EFFRAIN, ESQ.
STURSBERG & VEITH
405 LEXINGTON AVENUE, SUITE 4949, NEW YORK, NY 10174-4902
(212) 922-1177
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
12/16/99
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
* The remainder of this cover page shall be filed out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
<PAGE>
CUSIP No. 13D
287166102
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
ALEXANDER NASH
###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
SC THE SHARES WERE ACQUIRED AS PART OF A SHARE EXCHANGE ON A ONE-FOR ONE
BASIS WITH ELK ASSOCIATES CAPITAL CORPORATION
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 39,600
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH 64,150
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 39,600
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
64,150
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
103,750
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.59%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Schedule 13D
Item 1. Security and Issuer
This statement relates to the Common Stock, Par Value $.0001 of Ameritrans
Capital Corporation, 747 Third Avenue, 4th Floor, New York, NY 10017.
Item 2. Identity and Background
(a) Alexander Nash
(b) 12 Ridgeway
Kings Point, NY 11024
(c) Physician
(d) None
(e) None
(f) USA
Item 3. Source and Amount of Funds or Other Consideration
The shares were acquired as part of a share exchange, on a one-for-one
basis, with Elk Associates Capital Corporation.
Item 4. Purpose of Transaction
See Item 3
Item 5. Interest in Securities of the Issuer
See Items 7 through 13 of this Schedule 13D. To the knowledge of Alexander
Nash, the issuer has 1,745,600 shares of Common Stock, par value $.0001 per
share outstanding on the date hereof.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer.
None.
Item 7. Material to be Filed as Exhibits
None
<PAGE>
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: December 27, 1999 /s/ Alexander Nash
-----------------------------------
Signature
Alexander Nash
-----------------------------------
Name/Title
* Includes 6,500 shares held by Alexander Nash, M.D. as custodian for his
daughter. Also includes 53,650 shares held by his wife, as to which shares
Dr. Nash disclaims beneficial ownership.
